TABLE 1

Patients’ characteristics

Age years59.5 (30–86)
Males/females n11/5
Comorbidities
 Arterial hypertension11 (68.7%)
 Type 2 diabetes mellitus5 (31.2%)
 Malignancies2 (12.5%)
 Pre-existing respiratory diseases3 (18.7%)
 Other6 (37.5%)
Data at hospital admission
 Time between symptoms onset and admission days5 (0–15)
 Reported symptoms
  Fever ≥38.0°C14 (87.5%)
  Dyspnoea14 (87.5%)
  Cough7 (43.7%)
  Gastrointestinal symptoms2 (12.5%)
  Other3 (18.7%)
 Body temperature °C37.5 (37.2–38.9)
 Blood gas analysis#
  PaO2 mmHg69 (48–98)
  PaCO2 mmHg31 (27–38)
  pH7.46 (7.39–7.52)
  PaO2/FIO2 mmHg329 (228–467)
Laboratory findings
  Haemoglobin g·dL−113.8 (9.2–15.0)
  Red blood cells ×1012 per L4.7 (3–0–5.4)
  White blood cells ×109 per L8.6 (3.8–20.6)
  Neutrophils ×109 per L7.2 (3.9–18.9)
  Lymphocytes ×109 per L0.8 (0.4–2.0)
  Monocytes ×109 per L0.4 (0.1–3.0)
  Platelets ×109 per L231.0 (102.0–561.0)
  C-reactive protein g·dL−113.6 (1.1–37.5)
  Ferritin µg·L−1371 (80–1364)
  D-dimer µg·L−11256 (197–4473)
Respiratory support
 Oxygen12 (75.0%)
 Positive end-expiratory pressure7 (43.7%)
 High-flow nasal cannula1 (6.2%)
 Noninvasive ventilation0 (0%)
 Orotracheal intubation0 (0%)
Length of hospitalisation days25 (8–49)
Outcome
 Discharge home14 (87.5%)
 Intensive care unit0 (0%)
 Death2 (12.5%)
RT-PCR assays
 Nasopharyngeal swabs66 (89.2%)
 BALF6 (8.1%)
 Rectal swabs2 (2.7%)
RT-PCR repetitions during hospital stay/time from symptom onset days
 316 (100%)/8 (2–20)
 413 (81.2%)/18 (9–27)
 59 (56.2%)/21 (10–27)
 64 (25.0%)/24 (17–24)
RT-PCR positive results
 Patients3 (18.7%)
 Testing3 (4.1%)
Anti-SARS-CoV-2 serum antibodies+
 IgM8 (88.9%)
 IgG9 (100%)
 Time from symptom onset days25 (20–35)

Data are presented as median (range) or n (%), unless otherwise stated. FIO2: inspiratory oxygen fraction; PaO2: arterial oxygen tension; PaCO2: arterial carbon dioxide tension; BALF: bronchoalveolar lavage fluid. #: FIO2 0.21; : after two first negative results; +: N=9.